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A new p-variant has been detected and structurally defined in a French male, with a life-long history of 
hemolytic anemia. This variant is moderately unstable and has a low oxygen affinity. The abnormal 
hemoglobin was not detected by standard electrophoretic procedures. It moved slightly slower than Hb 
A during isoelectric focusing (IEF). Two minor fractions were also seen; the first migrated just cathodal 
to Hb F, as did partially oxidized Hb A or hemichrome derivatives of some unstable hemoglobins; the 
second in the position of free a-chains. The abnormal P-chain was readily separated from both ,&A- and 
aA-chains by acid-urea-Triton globin chain electrophoresis. Structural study was conducted 
simultaneously by fingerprinting and high-performance liquid chromatography (HPLC) of tryptic 
peptides. A new mutation P38(C4)Thr --‘Pro was found, which was named Hb Hazebrouck. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Molecular instability in the different variants 
of human adult hemoglobin has been docu- 
mented in about 65 cases. Among these, about 
42 involved the P-chain. The perturbation of oxy- 
gen affinity in these variants is frequent, but a 
low affinity has seldom been described. The most 
studied of these variants are Hb Hammer- 
smith /342(CDl)Phe--+Ser [l], Hb Louisville 
/342(CDl)Phe-+Leu (2) and Hb Niteroi p43-45 
deleted [3]. The modified residues alter both the 
a& contacts and the heme pocket. In such cases, 
anemia is determined both by hemolysis and low 
oxygen affinity. Here we report, for the first 
time a p-variant, Hb Hazebrouck a& 
38(C4)Thr-Pro. 
Standard hematological procedures were fol- 
lowed. Heinz body staining was performed with 
Cresyl brilliant blue (1%) after 3 h sterile incuba- 
tion at 37°C. Freshly prepared hemolysates were 
subjected to the 4 electrophoretic systems as pro- 
posed in [4]. Electrophoresis at alkaline pH (Tris- 
EDTA-borate buffer) was performed on cellulose 
acetate strips (Helena Titan III H), citrate agar 
electrophoresis (pH 6.2) on agar from Helena 
(Titan IV), and globin chain electrophoresis in 6 M 
urea, 1% P-mercaptoethanol (pH 6 and 9) on 
cellulose acetate strips (Sepraphore X Gelman). 
Isoelectric focusing (IEF) was carried out on a 
thin-layer polyacrylamide gel (pH 6-9) as in [5]. 
Densitometry of IEF slabs was done with a 
Cellosystem Sebia densitometer (France). Globin 
chain analysis on acid-urea-Triton acrylamide gel 
was performed as in [6]. Quantification of Hb F * To whom correspondence should be addressed 
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was as in [7] and the Hb Al level was measured 
chromatographically as in [8]. Glycosylated Hb 
(Hb Ai,) was estimated by an automatic apparatus 
using Biorex 70 chromatography as in [9]. Stability 
was tested by the isopropanol test as in [lo]. The 
methemoglobin fraction in the fresh hemolysate 
was spectrophotometrically evaluated with a Cary 
118 C instrument. The oxygen affinity of the 
whole blood was determined with an Aminco 
Hemoscan (Silver Springs, USA) and the 2-3 DPG 
assay was performed as in [l 11. The abnormal /3- 
chain was precipitated during 30-min incubation 
with p-mercuribenzoate (pMB) as in [ 121. Purity of 
the abnormal Hb after precipitation was controlled 
by acid-urea-Triton electrophoresis and then sub- 
jected to desheminisation by acid-acetone precipi- 
tation, separated by CM-cellulose chromatogra- 
phy [13], aminoethylated, and stripped of urea on 
a Biogel PZ (Bio-Rad) column. Two methods were 
used for the analysis of tryptic peptides: (i) finger- 
printing on silica gel thin-layer plates [14] and 
specific staining for histidine, tyrosine, trypto- 
phan, arginine and methionine [15]; (ii) HPLC 
using a Beckman model 343 with an Altex wave- 
length detector set at 214 nm. The column system 
was a Waters PBondapack C-18 (10 pm, ID 
3.9 mm, 30 cm). The solvent system was based on 
[16]: solvent A, 0.02 M ammonium acetate (pH 
5.7); solvent B, 0.01 M ammonium acetate (pH 
5.7) mixed 50/50 with acetonitrile (Baker, v/v). 
The gradient was linear from 0 to 60% in 50 min 
and from 60 to 100% in 10 min. Amino acid com- 
position was determined on a Biotronik 6000 1E 
(Biotronik, Munich) after 40 h hydrochloric acid 
hydrolysis of separated peptides. 
3. RESULTS 
3.1. Case report 
The patient was a 30-year-old French male 
whose family comes from the north of France near 
Hazebrouck. Other carriers of the trait were 
detected in the family. The propositus had well 
tolerated hemolytic anemia with slight cyanosis. 
Typical red cell indices were: Hb, 10.8 g/dl; RBC, 
3.56 1012/1; PCV, 29.5%; MCV, 83; reticulocytes, 
300 x 109/1. Numerous Heinz bodies were seen 
after 3 h incubation with Cresyl brilliant blue. The 
abnormal hemoglobin was undetectable by the 4 
standard electrophoreses. IEF showed 3 abnormal 
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Fig.1. IEF in a pH 6-9 gradient of the propositus 
hemolysate (2). The main fraction is X( 1) and the minor 
one X(2), X, abnormal hemoglobin Hazebrouck. 1 and 
3, mixed controls. 
fractions migrating cathodically to Hb A (fig.1). 
The main band was very close to Hb A, amounting 
to 31% as evaluated by densitometry. The second 
was slightly slower than Hb F and amounted to 
2.5-5% on successive IEF. A faint hemoglobin 
fraction in the position of a-chains was regularly 
seen. An abnormal P-chain was visualized by 
acid-urea-Triton electrophoresis (fig.2). Hb A2 
was 3.64% (N = 2.1 - 3.1) and Hb F 0.42% 
(N I 1). The elution pattern from Biorex 70 
chromatography had no distinctive feature and Hb 
123 
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Fig.2. Acid-urea-Triton electrophoresis pattern of Hb 
Hazebrouck whole hemolysate (2) and of the 
precipitated total Hazebrouck. Globin (1) compared to 
an Hb A control (3). 
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Table 1 
Amino acid composition of the abnormal BT4 obtained 
by HPLC 
Thr 
Glu 
Pro 
Val 
Leu 
Tyr 
Arg 
PAT4 Hazebrouck 
expected @T4 HPLC 
1 - 
1 1.1 
1 1.8 
1 1.1 
2 2.1 
1 0.9 
1 1.0 
Ai, was lower than normal: 2.8% (N = 4.6 - 
6.2). The isopropanol test was positive after 3 min. 
The whole blood PSO was 36 mmHg (N = 27 -+ 
29) and 2-3 DPG 18.6 PM/g of total Hb (N = 13 
- 17). The level of ferrihemoglobin in the fresh 
hemolysate was below 1%. 
3.2. Structural studies 
Fingerprints of the tryptic hydrolysate of the 
isolated abnormal P-chain prepared from pCMB- 
precipitated total globin showed normal spots. 
Specific staining for histidine, tyrosine, tryp- 
tophan, arginine and methionine was normal. 
Then, each individual spot was analysed for its 
amino acid composition. All had the expected 
composition, except BT4 were the threonine nor- 
mally present was absent and replaced by an addi- 
tional proline. 
An HPLC trace of the same tryptic hydrolysate 
showed a normal pattern. All the isolated peptides 
had the expected amino acid composition, except 
the peak in the place of PAT4 where the threonine 
residue was missing, being replaced by one proline 
(table 1). 
4. DISCUSSION 
Hb Hazebrouck is the first occurrence of Hb 
mutation with the Thr-Pro substitution. This 
substitution is allowed by the genetic coda and the 
published sequence of the human P-gene [17] Thr- 
P38 : ACC-Pro : CCC. The substitution @38 
Thr-Pro was demonstrated by amino acid 
analysis of the abnormal flT4 and this new variant 
was named Hb Hazebrouck according to the 
origin. This unstable hemoglobin produces 
discrete, compensated hemolytic anemia due to the 
effect of the low oxygen affinity. In our patient, 
the Pso of whole blood is higher than expected for 
the observed level of 2-3 DPG. 
The presence of this abnormal unstable 
hemoglobin was easily detectable by the standard 
methods of detection of unstable Hbs: presence of 
Heinz bodies, stability test, globin chain elec- 
trophoresis in the presence of urea-Triton and by 
IEF of the hemolysates. This method was able to 
separate two minor components: the first with a pl 
close to that of Hb F and different from the 
hemichrome observed in Hb St Louis which 
migrated close to the valency hybrid 1Br1 [18]; the 
second with the IEF pattern of free P-chains fre- 
quently associated with unstable P-variants. 
Further studies are in progress to investigate the 
molecular mechanisms of instability and low ox- 
ygen affinity determined by this point mutation in- 
troducing a proline in the C helix in contact with 
the heme pocket. One must consider that it is the 
first example of substitution in Thr (C4) which is 
an invariant residue, in contact with heme and 
located between residues P37(C3)Trp and 
@40(C6)Arg, which are greatly involved in al& 
contacts. Considering the model of deox- 
yhemoglobin described in [ 191, the substitution 
/338 Thr-Pro occurs at the 01~02 contact, which 
forms the two-way switch between the T and R 
quaternary structures. Pro in position 38 fixes the 
switch in the T structure. Subunit dissociation will 
be studied to compare what will occur with the 
close variants Hb Rotschild 037 Trp-Arg [20], 
Hb Hirose 037 Trp-Ser [21] and Hb Philly fl35 
Tyr-Phe [22]. 
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